PI3K/AKT/mTOR axis in vascular malformations: from molecular insights to targeted clinical trials

Yuan-Yang Zheng, Chen Hua, Xiao-Xi Lin · 2025

Read PI3K/AKT/mTOR axis in vascular malformations: from molecular insights to targeted clinical trials by Yuan-Yang Zheng, Chen Hua, Xiao-Xi Lin (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12723890.txt.

Description

Yuan-Yang Zheng, Chen Hua, and Xiao-Xi Lin review a signaling pathway at the heart of many vascular malformations, abnormal tangles of blood or lymph vessels present from birth. Genetics has pinned much of the blame on the PI3K/AKT/mTOR axis, a chain of molecular switches that normally governs cell growth, movement, and metabolism in vessel linings.

When the pathway sticks in the on position, it drives the slow-flow malformations and the overgrowth syndromes tied to the PIK3CA gene, and evidence increasingly links it to fast-flow lesions too. That makes the pathway an inviting drug target. The review moves from mechanism to medicine, summarizing trials of pathway inhibitors and the logic of combining them. The authors argue that future progress depends on selective drugs, sensible combinations guided by each patient's mutation profile, and careful validation to keep resistance and side effects down.

Catalog record

CREATORYuan-Yang Zheng, Chen Hua, Xiao-Xi Lin
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12723890

Browse the full library · About the Tower of Babel